|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-1-4
|
|
pubmed:abstractText |
Although clinical experience with liposomal doxorubicin is still limited in solid tumours, single agent Caelyx (pegylated liposomal doxorubicin) treatment has shown promising results in AIDS-related Kaposi's sarcoma, metastatic breast and ovarian cancer and anecdotally in other solid tumours. This is the first report of its use in small-cell lung cancer (SCLC). The objective of this multicenter phase II study was to evaluate the safety, tolerance and anti-tumour activity of Caelyx as monotherapy in patients with recurrent SCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1395-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11142478-Aged,
pubmed-meshheading:11142478-Anemia,
pubmed-meshheading:11142478-Antibiotics, Antineoplastic,
pubmed-meshheading:11142478-Carcinoma, Small Cell,
pubmed-meshheading:11142478-Combined Modality Therapy,
pubmed-meshheading:11142478-Disease Progression,
pubmed-meshheading:11142478-Doxorubicin,
pubmed-meshheading:11142478-Female,
pubmed-meshheading:11142478-Humans,
pubmed-meshheading:11142478-Lung Neoplasms,
pubmed-meshheading:11142478-Male,
pubmed-meshheading:11142478-Middle Aged,
pubmed-meshheading:11142478-Neoplasm Metastasis,
pubmed-meshheading:11142478-Neoplasm Recurrence, Local,
pubmed-meshheading:11142478-Neutropenia,
pubmed-meshheading:11142478-Radiotherapy, Adjuvant,
pubmed-meshheading:11142478-Salvage Therapy,
pubmed-meshheading:11142478-Thrombocytopenia,
pubmed-meshheading:11142478-Treatment Failure
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.
|
|
pubmed:affiliation |
Agii Anargiri Cancer Hospital, Athens, Greece. hecogoff@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
